New hope for rare nerve tumor disorder: Multi-Drug trial launches
Disease control
Recruiting now
This study tests several experimental drugs in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves. The goal is to see if these drugs can shrink tumors and control the disease. About 109 participants will receive one of three dr…
Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC